PMV

Augustine Therapeutics N.V. is a biopharmaceutical company based in Gent, Belgium, focused on developing innovative therapies for patients suffering from Charcot-Marie-Tooth disease (CMT) and other neuromuscular disorders. Founded in 2019, the company is engaged in two drug discovery programs aimed at identifying novel selective HDAC6 inhibitors. These compounds are designed to prevent nerve degeneration and facilitate the repair of peripheral myelin and axons. Through its research and development efforts, Augustine Therapeutics seeks to enhance the quality of life for patients affected by these debilitating conditions.

Minze Health is a Belgian healthtech startup founded in 2015 and headquartered in Antwerp. The company specializes in developing digital health solutions aimed at addressing urinary tract issues, particularly focusing on urologic, pelvic health, and continence care. Its innovative platform supports the diagnostic, treatment, and remote patient monitoring of individuals experiencing lower urinary tract symptoms (LUTS). Minze Health's solutions are utilized by hospitals, urology practices, and pelvic floor rehabilitation centers globally, enabling healthcare providers to effectively diagnose and monitor patients both in clinical settings and private practices.

Confo Therapeutics is a drug discovery company based in Brussels, Belgium, founded in 2015. The company specializes in developing internal drug discovery programs focused on G-protein coupled receptors (GPCRs) to address unmet medical needs. Utilizing its proprietary CONFO technology, Confo Therapeutics stabilizes the inherently unstable functional conformations of GPCRs, providing a robust framework for drug discovery. This innovative approach reveals previously inaccessible structural features of these receptors, facilitating the discovery of novel agonists and enhancing therapeutic interventions. By concentrating on stabilizing GPCRs, Confo Therapeutics aims to significantly advance the development of new treatments in the medical field.

Augustine Therapeutics N.V. is a biopharmaceutical company based in Gent, Belgium, focused on developing innovative therapies for patients suffering from Charcot-Marie-Tooth disease (CMT) and other neuromuscular disorders. Founded in 2019, the company is engaged in two drug discovery programs aimed at identifying novel selective HDAC6 inhibitors. These compounds are designed to prevent nerve degeneration and facilitate the repair of peripheral myelin and axons. Through its research and development efforts, Augustine Therapeutics seeks to enhance the quality of life for patients affected by these debilitating conditions.

Gorilla is a company focused on transforming the energy and utility industry through innovative data applications. It addresses longstanding data challenges that have hindered innovation across various sectors by offering a robust architectural data foundation tailored specifically for energy companies. Gorilla's platform features a flexible data model, a stable environment, and reusable algorithms designed to streamline data collection, processing, and reporting. This enables energy companies to harness data-driven technology for enhanced pricing, forecasting, and reporting, ultimately increasing sales while minimizing risk. With offices in Antwerp, London, Austin, and Melbourne, Gorilla is committed to accelerating digital transformation within the energy sector.

MICLEDI Microdisplays BV is a Belgium-based company that specializes in the design and manufacture of micro light emitting diode (LED) display chips for augmented reality (AR) glasses. As a fabless developer, MICLEDI focuses on innovative technologies that combine III/V materials processing with 3D integration and 300mm silicon-based processing. The company aims to deliver high-quality, power-efficient AR displays by utilizing a proprietary ASIC, which allows for the creation of compact and self-contained display modules. Serving the semiconductor industry, MICLEDI is positioned at the forefront of microLED technology, contributing to the advancement of augmented reality applications.

IVEX is a technology company specializing in the development of tools and software for the testing and validation of advanced driver-assistance systems (ADAS) and autonomous driving (AD) vehicles. Originating from the University of Leuven, IVEX has assembled a diverse team from over ten countries and has established partnerships with prominent industry players, including Siemens. The company focuses on enhancing the efficiency of engineers who analyze extensive driving data generated by AD/ADAS systems. IVEX offers a cloud-based suite of testing and validation tools, alongside an onboard real-time safety checker, which can function independently or in tandem. Its software solutions enable the identification and categorization of driving scenarios, the creation of digital representations for simulation, and the analysis of large datasets with reduced computational demands. By prioritizing safety and performance, IVEX positions itself as a critical player in the evolving landscape of automated vehicle technology.

Gorilla is a company focused on transforming the energy and utility industry through innovative data applications. It addresses longstanding data challenges that have hindered innovation across various sectors by offering a robust architectural data foundation tailored specifically for energy companies. Gorilla's platform features a flexible data model, a stable environment, and reusable algorithms designed to streamline data collection, processing, and reporting. This enables energy companies to harness data-driven technology for enhanced pricing, forecasting, and reporting, ultimately increasing sales while minimizing risk. With offices in Antwerp, London, Austin, and Melbourne, Gorilla is committed to accelerating digital transformation within the energy sector.

Minze Health is a Belgian healthtech startup founded in 2015 and headquartered in Antwerp. The company specializes in developing digital health solutions aimed at addressing urinary tract issues, particularly focusing on urologic, pelvic health, and continence care. Its innovative platform supports the diagnostic, treatment, and remote patient monitoring of individuals experiencing lower urinary tract symptoms (LUTS). Minze Health's solutions are utilized by hospitals, urology practices, and pelvic floor rehabilitation centers globally, enabling healthcare providers to effectively diagnose and monitor patients both in clinical settings and private practices.

eTheRNA Immunotherapies NV is a Belgium-based biotechnology company that specializes in the development of mRNA-based immunotherapies. Founded in 2013 and located in Niel, the company focuses on harnessing the immune system's dendritic cells to create treatments for melanoma, triple-negative breast cancer, and infectious diseases. eTheRNA has developed innovative TriMix technology that enhances the immune response, enabling patients to better combat these diseases. The company aims to be a leader in nucleic acid-based medicines, collaborating with partners to facilitate the creation of new drugs and improve patient outcomes. Additionally, eTheRNA has established a strategic partnership with China Grand Pharmaceutical and Healthcare Holdings Limited to further its mission.

CHILI Publish is a software company that specializes in online document editing solutions, transforming original designs into Smart Templates. Founded in 2010 and headquartered in Erembodegem, Belgium, CHILI Publish aims to simplify and automate graphic creation for businesses across various sectors, including marketing, retail, cosmetics, and food and beverage. Its innovative platform allows clients to generate on-brand visual communication for both print and packaging, significantly improving operational efficiency by eliminating repetitive tasks. The software is widely adopted by major and niche brands globally and integrates seamlessly with a broad network of third-party partners, providing a self-service environment for producing graphics efficiently.

Sweepatic is a cybersecurity company headquartered in Belgium that specializes in External Attack Surface Management. Its cloud-based platform continuously maps, monitors, and manages internet-connected assets and associated risks, operating around the clock. By delivering high-impact insights and notifications through an intuitive dashboard, Sweepatic helps organizations identify and mitigate vulnerabilities in their external attack surfaces. This proactive approach enhances cyber resilience and reduces the likelihood of becoming targets for cybercriminals.

reMYND NV is a biotechnology company based in Leuven, Belgium, focused on developing disease-modifying treatments for neurodegenerative and metabolic disorders, including Alzheimer’s, Parkinson’s, and diabetes. The company is known for its investigational compounds, such as ReS19-T, aimed at treating Alzheimer’s, and ReS39, which targets diabetes. Additionally, reMYND is advancing ReS3-T, a program that addresses both Alzheimer’s and epilepsy by regulating neuronal activity. The company utilizes a phenotypic screening platform to discover small molecule treatments that counteract the toxicity of misfolded proteins associated with these diseases. As a contract research organization (CRO), reMYND also assists clients, including major pharmaceutical companies in the United States, Europe, and Japan, by providing in-vivo assessments of experimental treatments using proprietary mouse models. Founded in 2002, reMYND has established a reputation for delivering pivotal proof-of-concept data that supports drug development in protein misfolding disorders.

SettleMint is a developer of a user-friendly blockchain platform that allows web2 engineers to build, deploy, and integrate applications on web3 infrastructure. Its low-code platform encompasses the entire web3 application development lifecycle, featuring node hosting as a service that enables quick deployment across various protocols and cloud regions. The platform offers a library of customizable smart contract templates for over 50 use cases, efficient data querying through full Graph QL integration, and decentralized data storage via IPFS nodes. Additionally, SettleMint provides an automated user interface builder and scalable resources for deployed services. The company, SOC2 certified and designed for enterprise use, aims to simplify web3 development by reducing complexity and risk. With a presence in Europe, the Middle East, India, and Asia-Pacific, SettleMint operates offices in several major cities, including Belgium, Dubai, Delhi, Singapore, and Tokyo.

CHILI Publish is a software company that specializes in online document editing solutions, transforming original designs into Smart Templates. Founded in 2010 and headquartered in Erembodegem, Belgium, CHILI Publish aims to simplify and automate graphic creation for businesses across various sectors, including marketing, retail, cosmetics, and food and beverage. Its innovative platform allows clients to generate on-brand visual communication for both print and packaging, significantly improving operational efficiency by eliminating repetitive tasks. The software is widely adopted by major and niche brands globally and integrates seamlessly with a broad network of third-party partners, providing a self-service environment for producing graphics efficiently.

eTheRNA Immunotherapies NV is a Belgium-based biotechnology company that specializes in the development of mRNA-based immunotherapies. Founded in 2013 and located in Niel, the company focuses on harnessing the immune system's dendritic cells to create treatments for melanoma, triple-negative breast cancer, and infectious diseases. eTheRNA has developed innovative TriMix technology that enhances the immune response, enabling patients to better combat these diseases. The company aims to be a leader in nucleic acid-based medicines, collaborating with partners to facilitate the creation of new drugs and improve patient outcomes. Additionally, eTheRNA has established a strategic partnership with China Grand Pharmaceutical and Healthcare Holdings Limited to further its mission.

QustomDot is a company based in Ghent, Belgium, specializing in the development and manufacturing of on-chip grade, cadmium-free quantum dots. These tiny semiconductor nanoparticles are designed for color conversion, allowing them to transform ultraviolet or blue light into pure colors. QustomDot's products enhance image quality and energy efficiency in various applications, including LED and LCD television screens, smartphones, smartwatches, and virtual or augmented reality goggles. Founded in 2020, the company also supports clients in effectively integrating quantum dots into their products, thereby improving the overall display performance and capabilities.

IVEX is a technology company specializing in the development of tools and software for the testing and validation of advanced driver-assistance systems (ADAS) and autonomous driving (AD) vehicles. Originating from the University of Leuven, IVEX has assembled a diverse team from over ten countries and has established partnerships with prominent industry players, including Siemens. The company focuses on enhancing the efficiency of engineers who analyze extensive driving data generated by AD/ADAS systems. IVEX offers a cloud-based suite of testing and validation tools, alongside an onboard real-time safety checker, which can function independently or in tandem. Its software solutions enable the identification and categorization of driving scenarios, the creation of digital representations for simulation, and the analysis of large datasets with reduced computational demands. By prioritizing safety and performance, IVEX positions itself as a critical player in the evolving landscape of automated vehicle technology.

MICLEDI Microdisplays BV is a Belgium-based company that specializes in the design and manufacture of micro light emitting diode (LED) display chips for augmented reality (AR) glasses. As a fabless developer, MICLEDI focuses on innovative technologies that combine III/V materials processing with 3D integration and 300mm silicon-based processing. The company aims to deliver high-quality, power-efficient AR displays by utilizing a proprietary ASIC, which allows for the creation of compact and self-contained display modules. Serving the semiconductor industry, MICLEDI is positioned at the forefront of microLED technology, contributing to the advancement of augmented reality applications.

Augustine Therapeutics N.V. is a biopharmaceutical company based in Gent, Belgium, focused on developing innovative therapies for patients suffering from Charcot-Marie-Tooth disease (CMT) and other neuromuscular disorders. Founded in 2019, the company is engaged in two drug discovery programs aimed at identifying novel selective HDAC6 inhibitors. These compounds are designed to prevent nerve degeneration and facilitate the repair of peripheral myelin and axons. Through its research and development efforts, Augustine Therapeutics seeks to enhance the quality of life for patients affected by these debilitating conditions.

Biotalys is an agricultural technology company based in Ghent, Belgium, founded in 2013. The company specializes in researching and developing biopesticides designed to control pests and diseases on crops and harvested products. Biotalys employs its proprietary Agrobody technology platform to create protein-based biocontrol solutions that combine the effectiveness of chemical pesticides with the safety profile of biologicals. These solutions are suitable for both pre- and post-harvest applications, aiming to provide a more sustainable and safer food supply. The company's technology platform generates products that enable targeted delivery and retention of active ingredients to prevent and control weeds, pests, and diseases.

Unifly is a developer of unmanned traffic management software focused on the secure integration of drones into global airspace. Founded in 2015 by aerospace experts, the company emerged from a vision shared by air traffic controllers who recognized the need for effective management of the increasing number of drones. Unifly's award-winning platform connects authorities and drone operators, allowing for real-time monitoring and management of drone traffic, while providing pilots with essential information regarding the legal status of their flights. The platform is already utilized by national authorities in Germany, Denmark, Austria, and Belgium, and Unifly is also active in the United States and several projects worldwide, including Africa and Asia. By fostering collaboration with various stakeholders, Unifly aims to enhance airspace safety and facilitate the seamless integration of drones into everyday life, addressing critical concerns regarding safety and oversight in both recreational and commercial drone activities.

Confo Therapeutics is a drug discovery company based in Brussels, Belgium, founded in 2015. The company specializes in developing internal drug discovery programs focused on G-protein coupled receptors (GPCRs) to address unmet medical needs. Utilizing its proprietary CONFO technology, Confo Therapeutics stabilizes the inherently unstable functional conformations of GPCRs, providing a robust framework for drug discovery. This innovative approach reveals previously inaccessible structural features of these receptors, facilitating the discovery of novel agonists and enhancing therapeutic interventions. By concentrating on stabilizing GPCRs, Confo Therapeutics aims to significantly advance the development of new treatments in the medical field.

SupplyStack, based in Antwerp, Belgium, specializes in providing advanced visibility solutions for real-time monitoring of transport orders. The company, which was formerly known as Slickss, offers a comprehensive platform that combines cutting-edge visibility tools with a robust transport management system. This platform facilitates collaboration among logistics service providers and shippers, enabling them to find carriers and effectively monitor their performance. SupplyStack serves a diverse range of industries, including automotive, industrial manufacturing, FMCG, chemicals, and pharmaceuticals, among others. By delivering real-time insights and automated processes, SupplyStack aims to enhance logistics efficiency, reduce costs, and improve the overall service experience for its customers.

reMYND NV is a biotechnology company based in Leuven, Belgium, focused on developing disease-modifying treatments for neurodegenerative and metabolic disorders, including Alzheimer’s, Parkinson’s, and diabetes. The company is known for its investigational compounds, such as ReS19-T, aimed at treating Alzheimer’s, and ReS39, which targets diabetes. Additionally, reMYND is advancing ReS3-T, a program that addresses both Alzheimer’s and epilepsy by regulating neuronal activity. The company utilizes a phenotypic screening platform to discover small molecule treatments that counteract the toxicity of misfolded proteins associated with these diseases. As a contract research organization (CRO), reMYND also assists clients, including major pharmaceutical companies in the United States, Europe, and Japan, by providing in-vivo assessments of experimental treatments using proprietary mouse models. Founded in 2002, reMYND has established a reputation for delivering pivotal proof-of-concept data that supports drug development in protein misfolding disorders.

Teamleader, based in Belgium, is a software company specializing in project management and invoicing solutions for businesses. The company offers a platform that integrates sales, project management, calendar and time tracking, invoicing, and ticketing functionalities, aimed at simplifying daily operations for entrepreneurs. With a user-friendly interface and competitive pricing, Teamleader currently serves over 7,000 paying customers and has experienced significant growth, positioning itself for further expansion. Its comprehensive approach allows clients to streamline their processes, save time, and enhance revenue generation.

Unifiedpost Group is a Belgian company that specializes in providing a cloud-based platform for administrative and financial services. Founded in 2001 and headquartered in La Hulpe, it facilitates digital connections between businesses, suppliers, and customers across various sectors, including corporate, government, agriculture, and construction. The company offers a range of solutions, including document processing, identity verification, payment automation, and procurement services, aimed at simplifying and enhancing business operations. Its invoicing solutions help organizations transition to electronic invoicing while ensuring compliance with local tax regulations. Additionally, Unifiedpost Group provides flexible invoice financing options to help small and medium-sized enterprises access working capital when needed. Overall, the company's platform is designed to streamline financial transactions and improve operational efficiency for its clients.

Ontoforce is a company that specializes in enhancing research and drug development for life sciences organizations by facilitating access to hidden insights within data. The company’s flagship product, DISQOVER, is a sophisticated data and knowledge platform designed specifically for the life sciences sector. Utilizing semantic technology and an ontology-based knowledge graph, DISQOVER integrates an organization’s internal data with licensed and public data, allowing users to explore and analyze information efficiently. The platform is user-friendly and customizable, catering to a diverse array of professionals, including scientific researchers, bioinformaticians, and data scientists. With over 10,000 users globally, Ontoforce is recognized for its impact on the pharmaceutical and biotechnology industries. The company is headquartered in Ghent, Belgium, with an additional office located in Cambridge, Massachusetts.

Aelin Therapeutics is a privately held Belgian biotherapeutics company founded in 2017, based in Heverlee. The company develops antibiotics and therapeutics using its proprietary Pept-in technology, which leverages protein aggregation to induce functional knockdown of target proteins. This approach allows for the rational design of novel biotherapeutics that can address undruggable human targets and combat resistant bacteria like Methicillin-resistant Staphylococcus aureus (MRSA). Aelin Therapeutics' platform offers a unique mode of action and intracellular target space, differentiating it from traditional small molecule drugs or protein-based therapeutics. The company's technology has shown applications in various areas including bacteria, cancer cells, fungi, viruses, and plant cells, with supporting preclinical Proof of Concept data published in high-impact journals such as Science.

Laminaria is a company based in Ostend, Belgium, founded in 2011, that specializes in the manufacturing of wave energy converter equipment. Through its innovative technology, Laminaria contributes to the renewable energy sector by harnessing ocean wave motion to generate power. The company focuses on developing systems that convert tilting and translating movements of waves into electrical energy, transferring this motion through mooring ropes to connected generators. As a leader in the field, Laminaria heads a consortium of ocean energy experts for the LAMWEC project, collaborating with organizations such as EMEC, Innosea, Ghent University, and TTI Testing to advance wave energy technology and its applications.

Biotalys is an agricultural technology company based in Ghent, Belgium, founded in 2013. The company specializes in researching and developing biopesticides designed to control pests and diseases on crops and harvested products. Biotalys employs its proprietary Agrobody technology platform to create protein-based biocontrol solutions that combine the effectiveness of chemical pesticides with the safety profile of biologicals. These solutions are suitable for both pre- and post-harvest applications, aiming to provide a more sustainable and safer food supply. The company's technology platform generates products that enable targeted delivery and retention of active ingredients to prevent and control weeds, pests, and diseases.

Newtec is a Belgian company established in 1985, specializing in the design, development, and manufacture of advanced satellite communication equipment. With over 30 years of experience, Newtec offers a diverse range of products including modems, satellite terminals, hubs, modulators, demodulators, redundancy switches, and receivers. These technologies serve various sectors such as broadcasting, government and defense, IP trunking, and consumer and enterprise VSAT. The company is committed to innovation, continuously exploring new possibilities to meet the evolving needs of its customers. Newtec operates multiple regional offices and research and development centers across the globe, including locations in the United States, Singapore, China, the UAE, Brazil, Germany, and France, ensuring a broad reach and the capacity to support its clientele effectively.

VIRTEO NV is a Belgian company founded in 2013 and headquartered in Mechelen. It operates a Software as a Service (SaaS) platform designed to facilitate the recovery of unpaid invoices for various clients, including corporations, small and medium-sized enterprises (SMEs), public institutions, court bailiffs, and lawyers. The platform streamlines internal dunning and external debt collection processes, enabling creditors to work efficiently with their partners while maintaining transparency and compliance. By offering tools that help manage the practices of external collection agencies, VIRTEO empowers clients to adhere to socially responsible policies while improving recovery rates and reducing costs. The company's approach aims to balance the goals of financial recovery with ethical standards, enhancing the reputation of the debt collection industry.

Ontoforce is a company that specializes in enhancing research and drug development for life sciences organizations by facilitating access to hidden insights within data. The company’s flagship product, DISQOVER, is a sophisticated data and knowledge platform designed specifically for the life sciences sector. Utilizing semantic technology and an ontology-based knowledge graph, DISQOVER integrates an organization’s internal data with licensed and public data, allowing users to explore and analyze information efficiently. The platform is user-friendly and customizable, catering to a diverse array of professionals, including scientific researchers, bioinformaticians, and data scientists. With over 10,000 users globally, Ontoforce is recognized for its impact on the pharmaceutical and biotechnology industries. The company is headquartered in Ghent, Belgium, with an additional office located in Cambridge, Massachusetts.

Avantium is a Dutch technology company specializing in advanced high-throughput research and development for energy, chemicals, and pharmaceutical industries. Headquartered in Amsterdam with state-of-the-art laboratories, Avantium's proprietary technology accelerates product and process innovation while reducing costs. With over 70 global clients, including industry leaders, Avantium has proven its technology's validity and commercial viability. The company focuses on developing new biofuels, bio-based chemicals, and novel crystal forms of marketed drugs under patent. Its team comprises highly educated professionals in catalysis, crystallography, organic chemistry, engineering, statistics, cheminformatics, and software development, collaborating closely with partner R&D organizations to drive innovation.

eTheRNA Immunotherapies NV is a Belgium-based biotechnology company that specializes in the development of mRNA-based immunotherapies. Founded in 2013 and located in Niel, the company focuses on harnessing the immune system's dendritic cells to create treatments for melanoma, triple-negative breast cancer, and infectious diseases. eTheRNA has developed innovative TriMix technology that enhances the immune response, enabling patients to better combat these diseases. The company aims to be a leader in nucleic acid-based medicines, collaborating with partners to facilitate the creation of new drugs and improve patient outcomes. Additionally, eTheRNA has established a strategic partnership with China Grand Pharmaceutical and Healthcare Holdings Limited to further its mission.

Unifly is a developer of unmanned traffic management software focused on the secure integration of drones into global airspace. Founded in 2015 by aerospace experts, the company emerged from a vision shared by air traffic controllers who recognized the need for effective management of the increasing number of drones. Unifly's award-winning platform connects authorities and drone operators, allowing for real-time monitoring and management of drone traffic, while providing pilots with essential information regarding the legal status of their flights. The platform is already utilized by national authorities in Germany, Denmark, Austria, and Belgium, and Unifly is also active in the United States and several projects worldwide, including Africa and Asia. By fostering collaboration with various stakeholders, Unifly aims to enhance airspace safety and facilitate the seamless integration of drones into everyday life, addressing critical concerns regarding safety and oversight in both recreational and commercial drone activities.

neoScores is an innovative company based in Kontich, Belgium, that specializes in providing an online platform for purchasing and playing digital sheet music. Established in 2013 by three professional musicians—Bart Van der Roost, Bob Hamblok, and Jonas Coomans—the company aims to transform the way musicians access and utilize sheet music. The platform, known as Gustaf, is compatible across various operating systems and devices, enabling users to securely buy scores and share notes with fellow musicians from anywhere. With a focus on high-quality, flexible, and aesthetically pleasing digital scores, neoScores strives to enhance the musical experience for users, allowing them to engage with music seamlessly via smartphones, tablets, or computers.

Trod Medical S.A. is a medical device manufacturer founded in 2006, with its headquarters located in Leuven, Belgium, and a presence in the Tampa Bay area, USA. The company specializes in innovative ablation technologies, particularly in the development of radiofrequency (RF) ablation devices. Trod Medical's flagship product, the EncageTM, is a percutaneous RF device designed to ablate soft tissues with exceptional precision, significantly reducing collateral damage compared to conventional treatments. This advancement is particularly relevant in the treatment of prostate cancer, a prevalent condition that affects around 240,000 new patients annually in the United States. The company aims to address the limitations of existing therapies, which often lead to serious side effects such as erectile dysfunction and urinary incontinence. Through its focus on focal ablation techniques, Trod Medical is committed to improving patient outcomes and enhancing surgical efficacy.

Ontoforce is a company that specializes in enhancing research and drug development for life sciences organizations by facilitating access to hidden insights within data. The company’s flagship product, DISQOVER, is a sophisticated data and knowledge platform designed specifically for the life sciences sector. Utilizing semantic technology and an ontology-based knowledge graph, DISQOVER integrates an organization’s internal data with licensed and public data, allowing users to explore and analyze information efficiently. The platform is user-friendly and customizable, catering to a diverse array of professionals, including scientific researchers, bioinformaticians, and data scientists. With over 10,000 users globally, Ontoforce is recognized for its impact on the pharmaceutical and biotechnology industries. The company is headquartered in Ghent, Belgium, with an additional office located in Cambridge, Massachusetts.

Biotalys is an agricultural technology company based in Ghent, Belgium, founded in 2013. The company specializes in researching and developing biopesticides designed to control pests and diseases on crops and harvested products. Biotalys employs its proprietary Agrobody technology platform to create protein-based biocontrol solutions that combine the effectiveness of chemical pesticides with the safety profile of biologicals. These solutions are suitable for both pre- and post-harvest applications, aiming to provide a more sustainable and safer food supply. The company's technology platform generates products that enable targeted delivery and retention of active ingredients to prevent and control weeds, pests, and diseases.

Argenx is a global immunology company based in the Netherlands, dedicated to enhancing the lives of individuals affected by severe autoimmune diseases and cancer. The company specializes in antibody engineering technology to develop treatments for rare autoimmune conditions. Its lead product, Vyvgart (efgartigimod), received initial approval in the United States in December 2021 for the treatment of generalized myasthenia gravis, followed by subsequent approvals in Europe and Japan in 2022. Through its innovative approaches, Argenx aims to address significant unmet medical needs in the field of immunology.

Caliopa NV, established in 2010 in Zwijnaarde, Belgium, specializes in developing and marketing silicon photonics-based optical transceivers for the data communication and telecommunications industries. As a spin-off from Ghent University's Photonics Research Group and imec, Caliopa leverages advanced technologies to deliver high-performance, cost-effective solutions tailored to these sectors.

iNEWiT is an engineering company based in Mechelen, Belgium, founded in 2005. It specializes in identifying, designing, and creating applications and devices tailored for the mobile market. The company develops mobile video communication applications utilizing its patent-pending technology to transmit data, video, and sound across various wireless and wired platforms. iNEWiT also offers wireless communication technologies that encompass GPRS/EDGE, 3G, HSDPA/HSUPA, WiFi, WiMAX, and satellite networks. Additionally, it provides plug-and-play products aimed at the business-to-consumer markets.

Cinvolve is a company that specializes in seat occupation monitoring services, focusing on enhancing the understanding of audience behavior in movie theaters. Utilizing advanced sensor technology embedded in theater seating, Cinvolve provides real-time detection of seat occupancy, allowing cinema owners to gather and analyze valuable data regarding audience preferences and engagement. This innovative approach not only streamlines the ticketing process, eliminating the need for traditional ticket control services, but also empowers cinema operators and studios to adjust movie programming and scheduling based on audience feedback. Founded in 2004 and headquartered in Izegem, Belgium, Cinvolve aims to optimize the cinema experience by connecting theaters more effectively with their audiences.

iNEWiT is an engineering company based in Mechelen, Belgium, founded in 2005. It specializes in identifying, designing, and creating applications and devices tailored for the mobile market. The company develops mobile video communication applications utilizing its patent-pending technology to transmit data, video, and sound across various wireless and wired platforms. iNEWiT also offers wireless communication technologies that encompass GPRS/EDGE, 3G, HSDPA/HSUPA, WiFi, WiMAX, and satellite networks. Additionally, it provides plug-and-play products aimed at the business-to-consumer markets.